What exactly can a biomaterials expert offer the pharmaceutical industry in developing therapies that make life more comfortable and convenient for patients? One solution with huge potential in all kinds of disease prevention and management therapies is our sustained drug release biomaterials and expertise.
We work with our pharmaceutical partners to achieve their Target Product Profile (TPP) through unique implantable and injectable drug delivery formulations. With its sustained release, our TheraPEA™ polyester amide platform can enable longer-lasting therapies that increase patient comfort and their subsequent adherence to the therapy – while being compatible with a wide range of Active Pharmaceutical Ingredients (APIs).
Our expertise also brings additional strategic benefits to partners. Drawing on our wealth of IP, we can support your pre-clinical development activities and collaborate to leverage this even further by protecting and extending the lifetime of branded sales based on the new formulations we create.
We are proud to offer you a portfolio of customizable, combinable, and sustainable biomaterials that is unrivaled in the medical industry.
Contact us today to discover how our team can partner with you to enable new drug therapies in disease prevention and management.